Hemostasis, Thrombosis, and Vascular Biology Patients and Methods Subjects and Phenotypes Table 1. Results from the Linkage Analysis: Apcr with F5 Dna Variants, and Apcr Conditional on the Fvl Mutation
暂无分享,去创建一个
L. Almasy | J. Blangero | A. Buil | J. Fontcuberta | J. Soria | J. Mateo | M. Borrell | W. Stone | J. Souto | Santa Creu | Elisabeth Martínez-Sá Nchez | Mark Lathrop | Sant Pau | C. Sant | Antoni M | M. Lathrop
[1] L. Almasy,et al. Identification of a large deletion and three novel mutations in exon 13 of the factor V gene in a Spanish family with normal factor V coagulant and anticoagulant properties , 2002, Human Genetics.
[2] L. Almasy,et al. A quantitative-trait locus in the human factor XII gene influences both plasma factor XII levels and susceptibility to thrombotic disease. , 2002, American journal of human genetics.
[3] R. Bertina,et al. Elevated Factor VIII Levels and the Risk of Thrombosis , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[4] L. Almasy,et al. Genetic susceptibility to thrombosis and its relationship to physiological risk factors: the GAIT study. Genetic Analysis of Idiopathic Thrombophilia. , 2000, American journal of human genetics.
[5] L. Almasy,et al. Functional effects of the ABO locus polymorphism on plasma levels of von Willebrand factor, factor VIII, and activated partial thromboplastin time. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[6] L. Almasy,et al. Linkage analysis demonstrates that the prothrombin G20210A mutation jointly influences plasma prothrombin levels and risk of thrombosis , 2000 .
[7] L. Almasy,et al. Genetic determinants of hemostasis phenotypes in Spanish families. , 2000, Circulation.
[8] F. Rosendaal,et al. The HR2 Haplotype of Factor V: Effects on Factor V Levels, Normalized Activated Protein C Sensitivity Ratios and the Risk of Venous Thrombosis , 2000, Thrombosis and Haemostasis.
[9] T. Baglin,et al. The Factor V R2 Allele: Risk of Venous Thromboembolism, Factor V Levels and Resistance to Activated Protein C , 2000, Thrombosis and Haemostasis.
[10] P. van Eerdewegh,et al. Joint multipoint linkage analysis of multivariate qualitative and quantitative traits. I. Likelihood formulation and simulation results. , 1999, American journal of human genetics.
[11] A. Folsom,et al. Prospective study of markers of hemostatic function with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. , 1999, Circulation.
[12] N. Schork,et al. Testing the robustness of the likelihood-ratio test in a variance-component quantitative-trait loci-mapping procedure. , 1999, American journal of human genetics.
[13] F. Rosendaal,et al. A reduced sensitivity for activated protein C in the absence of factor V Leiden increases the risk of venous thrombosis. , 1999, Blood.
[14] L. Almasy,et al. Multipoint quantitative-trait linkage analysis in general pedigrees. , 1998, American journal of human genetics.
[15] R. Liang,et al. A novel mutation of Arg306 of factor V gene in Hong Kong Chinese. , 1998, Blood.
[16] T. Baglin,et al. Factor V Cambridge: a new mutation (Arg306-->Thr) associated with resistance to activated protein C. , 1998, Blood.
[17] A. Folsom,et al. Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. , 1997, Circulation.
[18] F. Bernardi,et al. New Coagulation Factor V Gene Polymorphisms Define a Single and Infrequent Haplotype Underlying the Factor V Leiden Mutation in Mediterranean Populations and Indians , 1997, Thrombosis and Haemostasis.
[19] M. Blombäck,et al. Search for mutations in the genes for coagulation factors V and VIII with a possible predisposition to activated protein C resistance , 1997, European journal of clinical investigation.
[20] P. Mannucci,et al. Inherited Thrombophilia*: Part 2 , 1996, Thrombosis and Haemostasis.
[21] J. Clegg,et al. Evidence for a single origin of factor V Leiden , 1996, British journal of haematology.
[22] N. Dzimiri,et al. World distribution of factor V Leiden , 1996, The Lancet.
[23] H. Büller,et al. Absence of mutations at the activated protein C cleavage sites of factor VIII in 125 patients with venous thrombosis , 1996, British journal of haematology.
[24] J. van der Meer,et al. Lowered APC-Sensitivity Ratio Related to Increased Factor VIII-Clotting Activity , 1995, Thrombosis and Haemostasis.
[25] J. Cooper,et al. Factor VIII, ABO blood group and the incidence of ischaemic heart disease , 1994, British journal of haematology.
[26] Pieter H. Reitsma,et al. Mutation in blood coagulation factor V associated with resistance to activated protein C , 1994, Nature.
[27] C. Amos. Robust variance-components approach for assessing genetic linkage in pedigrees. , 1994, American journal of human genetics.
[28] F. Rosendaal,et al. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study , 1993, The Lancet.
[29] E Feingold,et al. Gaussian models for genetic linkage analysis using complete high-resolution maps of identity by descent. , 1993, American journal of human genetics.
[30] B. Dahlbäck,et al. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[31] A. Dorner,et al. The role of von Willebrand factor multimers and propeptide cleavage in binding and stabilization of factor VIII. , 1991, The Journal of biological chemistry.
[32] Shirley A. Miller,et al. A simple salting out procedure for extracting DNA from human nucleated cells. , 1988, Nucleic acids research.
[33] J. Mathews,et al. Extensions to multivariate normal models for pedigree analysis , 1982, Annals of human genetics.
[34] M. Margaglione,et al. Coinheritance of the HR2 haplotype in the factor V gene confers an increased risk of venous thromboembolism to carriers of factor V R506Q (factor V Leiden). , 1999, Blood.
[35] J. Fontcuberta,et al. Patients with venous thromboembolism have a lower APC response than controls. Should this be regarded as a continuous risk factor for venous thrombosis? , 1999, Haematologica.
[36] E. Sacchi,et al. A factor V genetic component differing from factor V R506Q contributes to the activated protein C resistance phenotype. , 1997, Blood.
[37] L. Almasy,et al. Bivariate quantitative trait linkage analysis: Pleiotropy versus co‐incident linkages , 1997, Genetic epidemiology.
[38] L. Iacoviello,et al. Detection of New Polymorphic Markers in the Factor V Gene: Association with Factor V Levels in Plasma , 1996, Thrombosis and Haemostasis.
[39] L. Cavalli-Sforza,et al. Genetic variation and human disease , 1996 .
[40] K. Lange,et al. Ascertainment and goodness of fit of variance component models for pedigree data. , 1984, Progress in clinical and biological research.